REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,005,426 | -47.6% | 262,025 | +15.6% | 0.00% | -50.0% |
| Q2 2023 | $5,735,448 | -39.5% | 226,608 | -23.1% | 0.00% | -33.3% |
| Q1 2023 | $9,487,778 | -46.4% | 294,560 | -69.3% | 0.01% | -57.1% |
| Q4 2022 | $17,700,703 | -73.5% | 958,868 | -61.2% | 0.01% | -70.2% |
| Q3 2022 | $66,778,000 | +5320.3% | 2,473,257 | +2674.8% | 0.05% | +4600.0% |
| Q2 2022 | $1,232,000 | +407.0% | 89,132 | +615.9% | 0.00% | – |
| Q1 2022 | $243,000 | -89.9% | 12,451 | -91.6% | 0.00% | -100.0% |
| Q4 2021 | $2,417,000 | +206.3% | 148,110 | +423.1% | 0.00% | – |
| Q3 2021 | $789,000 | +101.3% | 28,313 | +114.2% | 0.00% | – |
| Q2 2021 | $392,000 | +44.6% | 13,218 | +36.0% | 0.00% | – |
| Q1 2021 | $271,000 | -51.7% | 9,717 | -50.9% | 0.00% | – |
| Q4 2020 | $561,000 | +99.6% | 19,775 | +76.5% | 0.00% | – |
| Q3 2020 | $281,000 | -55.3% | 11,204 | -56.5% | 0.00% | – |
| Q2 2020 | $629,000 | +101.0% | 25,736 | +21.9% | 0.00% | – |
| Q1 2020 | $313,000 | +26.2% | 21,112 | +38.1% | 0.00% | – |
| Q4 2019 | $248,000 | -29.1% | 15,282 | -43.3% | 0.00% | – |
| Q3 2019 | $350,000 | +4.5% | 26,939 | +4.3% | 0.00% | – |
| Q2 2019 | $335,000 | -20.8% | 25,821 | -3.8% | 0.00% | – |
| Q1 2019 | $423,000 | +4.4% | 26,837 | +33.5% | 0.00% | – |
| Q4 2018 | $405,000 | +90.1% | 20,108 | +134.5% | 0.00% | – |
| Q3 2018 | $213,000 | +3450.0% | 8,576 | +4043.0% | 0.00% | – |
| Q2 2018 | $6,000 | -45.5% | 207 | -39.8% | 0.00% | – |
| Q1 2018 | $11,000 | -21.4% | 344 | -14.9% | 0.00% | – |
| Q4 2017 | $14,000 | +75.0% | 404 | +45.8% | 0.00% | – |
| Q3 2017 | $8,000 | +33.3% | 277 | +15.4% | 0.00% | – |
| Q2 2017 | $6,000 | -14.3% | 240 | -23.3% | 0.00% | – |
| Q1 2017 | $7,000 | +16.7% | 313 | +16.4% | 0.00% | – |
| Q4 2016 | $6,000 | +50.0% | 269 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | -95.3% | 269 | -95.8% | 0.00% | – |
| Q2 2016 | $86,000 | -61.4% | 6,358 | -50.2% | 0.00% | – |
| Q1 2016 | $223,000 | -38.7% | 12,771 | +19.8% | 0.00% | – |
| Q4 2015 | $364,000 | – | 10,656 | +118300.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 9 | -99.7% | 0.00% | – |
| Q2 2015 | $106,000 | +8.2% | 3,304 | -30.3% | 0.00% | – |
| Q1 2015 | $98,000 | -26.3% | 4,738 | -39.6% | 0.00% | – |
| Q4 2014 | $133,000 | +2116.7% | 7,840 | +2513.3% | 0.00% | – |
| Q3 2014 | $6,000 | +200.0% | 300 | +417.2% | 0.00% | – |
| Q2 2014 | $2,000 | -94.3% | 58 | -94.8% | 0.00% | – |
| Q1 2014 | $35,000 | – | 1,109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |